Berlin (Germany) and Germantown, MD (U.S.A.), December 10, 2014 - Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics company, today announced that CEO/CFO Dr. Thomas Taapken will be presenting at the Oppenheimer 25th Annual Healthcare Conference on Wednesday, December 10, 2014, at 9.45 a.m. EST in room ACT IV of The Crowne Plaza Hotel in New York City, USA. The Oppenheimer 25th Annual Healthcare Conference will take place on December 10-11, 2014 and is one of the most important international investor conferences introducing a broad spectrum of public and private healthcare companies spanning all major sectors of the healthcare industry.
The presentation will be available on Epigenomics’ website: http://www.epigenomics.com/en/news-investors.html.
– Ends –
Contact Epigenomics AG
Antje Zeise, Manager IR | PR Epigenomics AG
Geneststraße 5
10829 Berlin Tel +49 (0) 30 24345 386 ir@epigenomics.com www.epigenomics.com
For US press inquiries: Epigenomics, Inc. 20271 Goldenrod Lane, Suite 2027 Germantown, Maryland 20876
pr@epigenomics.com
